Regenerative Medicine Solutions for Rotator Cuff Injuries in Athletes: Indications and Outcomes.
Journal
Sports medicine and arthroscopy review
ISSN: 1538-1951
Titre abrégé: Sports Med Arthrosc Rev
Pays: United States
ID NLM: 9315689
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
medline:
2
5
2024
pubmed:
2
5
2024
entrez:
2
5
2024
Statut:
ppublish
Résumé
Rotator cuff (RC) injuries include a wide range of pathologic states. Athletes are perhaps the most susceptible to RC injuries ranging from tendinopathy to partial or full-thickness tears, due to functional overload and repetitive movements, causing abstention from sports for long periods. Regenerative medicine keeps giving us multiple choices to fight the disability caused by these pathologies. A literature search was performed, and findings related to the structure-function of rotator cuff units, pathophysiology of injuries, regenerative medicine treatments, and future strategies were outlined. Platelet-rich plasma (PRP) has a greater number of articles and clinical trials, accompanied by stem cells progenitor, prolotherapy, and new approaches such as microfragmented adipose tissue and exosomes. RC injuries in athletes can cause pain, functional impotence, and the risk of recurrence, and can lead them to stop playing sports. Regenerative medicine offers a range of treatments, but some of them need further studies to underline their actual validity.
Identifiants
pubmed: 38695503
doi: 10.1097/JSA.0000000000000399
pii: 00132585-202403000-00008
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
46-50Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors declare no conflict of interest.
Références
Bakhsh W, Nicandri G. Anatomy and physical examination of the shoulder. Sports Med Arthrosc. 2018;26:E10–E22.
Nimura A, Kato A, Yamaguchi K, et al. The superior capsule of the shoulder joint complements the insertion of the rotator cuff. J Shoulder Elbow Surg. 2012;21:867–872.
Norkin C, White J. Measurements of Joint Motion: A Guide to Goniometry, 5th ed. F. A. Davis Company; 2017:1–592.
Zhang X, Wang D, Wang Z, et al. Clinical perspectives for repairing rotator cuff injuries with multi-tissue regenerative approaches. J OrthopTranslat. 2022;36:91–108.
Factor D, Dale B. Current concepts of rotator cuff tendinopathy. Int J Sports Phys Ther. 2014;9:274–288.
Giai Via A, De Cupis M, Spoliti M, et al. Clinical and biological aspects of rotator cuff tears. Muscles Ligaments Tendons J. 2013;3:70–79.
Shin KM. Partial-thickness rotator cuff tears. Korean J Pain. 2011;24:69–73.
Zaremski JL, Wasser JG, Vincent HK. Mechanisms and treatments for shoulder injuries in overhead throwing athletes. Curr Sports Med Rep. 2017;16:179–188.
Tashjian RZ. Epidemiology, natural history, and indications for treatment of rotator cuff tears. Clin Sports Med. 2012;31:589–604.
Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res. 2008;466:1539–1554.
Randelli P, Randelli F, Ragone, et al. Regenerative medicine in rotator cuffinjuries. Biomed Res Int. 2014;2014:129515. doi:10.1155/2014/129515
doi: 10.1155/2014/129515
Accousti KJ, Flatow EL. Technical pearls on how to maximize healing of the rotator cuff. Instr Course Lect. 2007;56:3.
Yang G, Rothrauff BB, Tuan RS. Tendon and ligament regeneration and repair: clinical relevance and developmental paradigm. Birth Defects Res C Embryo Today. 2013;99:203–222.
Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21:7794.
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158–167.
Le ADK, Enweze L, De Baun MR, et al. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11:624–634.
Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrates. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e51–e55.
Mishra A, Randelli P, Barr C, et al. Platelet-rich plasma and the upper extremity. Hand Clinics. 2012;vol. 28:481–491.
Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135–2140.
Anitua E, Andía I, Sanchez M, et al. Autologous preparations rich ingrowth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23:281–286.
Hoppe S, Alini M, Benneker LM, et al. Tenocytes of chronic rotator cuff tendon tears can be stimulated byplatelet-released growth factors. J Shoulder Elbow Surg. 2013;22:340–349.
Randelli PS, Arrigoni P, Maffulli N, et al. Autologous platelet rich plasma for arthroscopic rotator cuff repair. A pilot study. DisabilRehabil. 2008;30:1584–1589.
Lin MT, Wei KC, Wu CH. Effectiveness of platelet-rich plasma injection in rotator cuff tendinopathy: a systematic review and meta-analysis of randomized controlled trials. Diagnostics (Basel). 2020;10:189.
Rha DW, Park GY, Kim YK, et al. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection anddry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013;27:113–122.
Scarpone M, Rabago D, Snell E, et al. Effectiveness of platelet-rich plasma injection for rotator cuff tendinopathy: a prospective open-label study. GlobAdv Health Med. 2013;2:26–31.
Rossi LA, Piuzzi N, Giunta D, et al. Subacromial platelet-rich plasma injections decrease pain and improve functional outcomes in patients with refractory rotator cuff tendinopathy. Arthroscopy. 2021;37:2745–2753.
Kwong CA, Woodmass JM, Gusnowski EM, et al. Platelet-rich plasma in patients with partial-thickness rotator cuff tears or tendinopathy leads to significantly improved short-term pain relief and function compared with corticosteroid injection: a double-blind randomized controlled trial. Arthroscopy. 2021;37:510–517.
Jo CH, Lee SY, Yoon KS, et al. Allogeneic platelet-rich plasma versus corticosteroid injection for the treatment of rotator cuff disease: a randomized controlled trial. J Bone Joint Surg Am. 2020;102:2129–2137.
Pasin T, Ataoğlu S, Pasin Ö, et al. Comparison of the effectiveness of platelet-rich plasma, corticosteroid, and physical therapy in subacromial impingement syndrome. Arch Rheumatol. 2019;34:308–316.
Velasquez Garcia A, Ingala Martini L, Franco Abache A, et al. Role of platelet-rich plasma in the treatment of rotator cuff tendinopathy. World J Orthop. 2023;14:505–515.
Schneider A, Burr R, Garbis N, et al. Platelet-rich plasma and the shoulder: clinical indications and outcomes. Curr Rev Musculoskelet Med. 2018;11:593–597.
Bianco ST, Moser HL, Galatz LM, et al. Biologics and stem cell-based therapies for rotator cuff repair. Ann N Y Acad Sci. 2019;1442:35–47.
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147.
Mazzocca AD, McCarthy MBR, Chowaniec DM, et al. Rapid isolation of human stem cells (connective tissue progenitor cells) from the proximal humerus during arthroscopic rotator cuff surgery. Am J Sports Med. 2010;38:1438–1447.
Beitzel K, McCarthy MB, Cote MP, et al. Rapid isolation of human stem cells (connective progenitor cells) from the distal femur during arthroscopic knee surgery. Arthroscopy. 2012;28:74–84.
Randelli P, Conforti E, Piccoli M, et al. Isolation and characterization of 2 new human rotator cuff and long head of biceps tendon cells possessing stem cell-like self-renewal and multipotential differentiation capacity. Am J Sports Med. 2013;41:1653–1664.
Song N, Armstrong AD, Li F, et al. Multipotent mesenchymal stem cells from human subacromial bursa: potential for cellbased tendon tissue engineering. Tissue Eng Part A. 2014;20:239–249.
Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99:1285–1297.
Mocini F, Monteleone AS, Piazza P, et al. The role of adipose derived stem cells in the treatment of rotator cuff tears: from basic science to clinical application. Orthop Rev (Pavia). 2020;12(suppl 1):8682.
Kim YS, Sung CH, Chung SH, et al. Does an injection of adipose-derived mesenchymal stem cells loaded in fibrin glue influence rotator cuff repair outcomes? A clinical and magnetic resonance imaging study. Am J SportsMed. 2017;45:2010–2018.
Jo CH, Chai JW, Jeong EC, et al. Intratendinous injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of rotator cuff disease: a first-in-human trial: ad mscs injection for rc disease. Stem Cells. 2018;36:1441–1450.
Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. NatMed. 2007;13:1219–1227.
Randelli P, Cucchi D, Cabitza F, et al. Tendon-derived stem cells for rotator cuff repair. Oper Techn Orthop. 2016;26:147–154.
Hauser RA, Lackner JB, Steilen-Matias D, et al. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139–159.
Kim SR, Stitik TP, Foye PM, et al. Critical review of prolotherapy for osteoarthritis, low back pain, and other musculoskeletal conditions: a physiatric perspective. Am J Phys Med Rehabil. 2004;83:379–389.
Kim HJ, Kim SH, Yun DH. The effects of anti-inflammatory drugs on histologic findings of the experimental prolotherapy model. J Korean Acad Rehabil Med. 2006;30:378–384.
Bertrand H, Reeves KD, Bennett CJ, et al. Dextrose prolotherapy versus control injections in painful rotator cuff tendinopathy. Arch Phys Med Rehabil. 2016;97:17–25.
Lee DH, Kwack KS, Rah UW, et al. Prolotherapy for refractory rotator cuff disease: retrospective case-control study of 1-year follow-up. Arch Phys Med Rehabil. 2015;96:2027–2032.
Escaloni J, Mazloomdoost D, Young I. Novel orthobiologic preparation and regenerative rehabilitation of a complex shoulder injury in a competitive adolescent female athlete. Int J Sports Phys Ther. 2023;18:240–252.
Hogaboom N, Malanga G, Cherian C, et al. A pilot study to evaluate micro-fragmented adipose tissue injection under ultrasound guidance for the treatment of refractory rotator cuff disease in wheelchair users with spinal cord injury. J Spinal Cord Med. 2021;44:886–895.
Connor DE, Paulus JA, Dabestani PJ, et al. Therapeutic potential of exosomes in rotator cuff tendon healing. J Bone Miner Metabol. 2019;37:759–767.
Li J, Liu ZP, Xu C, et al. TGF-beta1-containing exosomes derived from bone marrow mesenchymal stem cells promote proliferation, migration and fibrotic activity in rotator cuff tenocytes. Regen Ther. 2020;15:70–76.